Study of the incidence of acute kidney injury in HCV infected patients receiving DAAs

Salma Fathy Rezk Thabet;

Abstract


Abstract
Background: Egypt had the highest burden of hepatitis C virus infection worldwide with genotype 4. The new direct-acting antivirals DAAs can target almost all steps of the HCV life cycle. The objective of our study was to detect AKI events during and on follow up after the end of treatment with combination DAAs. Aim of the work: to study the incidence of acute kidney injury in HCV infected patients receiving IFN-free combination new DAAs.


Other data

Title Study of the incidence of acute kidney injury in HCV infected patients receiving DAAs
Other Titles دراسة حالات الإصابة الكلوية الحادة فى المرضى المصابين بالعدوى بفيروس الالتهاب الكبد الوباءي الذين يتلقون العلاجات الحديثة المباشرة ضد الفيروس DAAs
Authors Salma Fathy Rezk Thabet
Issue Date 2018

Attached Files

File SizeFormat
J9165.pdf570.74 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.